These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 881082)

  • 21. Cromolyn prevents bronchospastic attacks caused by Bacillus Calmette Geurin immunotherapy for malignant melanoma patient.
    Wishnitzer R; Eliraz A; Fink A
    Ann Allergy; 1985 Aug; 55(2):167-9. PubMed ID: 3927789
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Primary inoculation tuberculosis after immunotherapy for malignant melanoma with BCG vaccine.
    Caplan SE; Kauffman CL
    J Am Acad Dermatol; 1996 Nov; 35(5 Pt 1):783-5. PubMed ID: 8912582
    [No Abstract]   [Full Text] [Related]  

  • 23. [Immunotherapy with BCG as coadjuvant in the management of malignant melanomas].
    Céspedes de Gómez MM; Aguilar Velázquez G; Valles de Cortés Y
    Alergia; 1980 Apr; 27(2):69-86. PubMed ID: 7416444
    [No Abstract]   [Full Text] [Related]  

  • 24. [BCG-treatment of malignant melanoma].
    Borberg H
    Internist (Berl); 1975 Oct; 16(10):482-5. PubMed ID: 1107254
    [No Abstract]   [Full Text] [Related]  

  • 25. [Results in the use of immunochemotherapy in patients with cutaneous malignant melanoma].
    Calbo L; Gorgone S; Palmeri R; Salibra M; Melita P
    Chir Ital; 1983 Aug; 35(4):519-25. PubMed ID: 6680859
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Possibilities of an immunotherapy of malignant skin tumors with particular consideration of malignant melanomas (author's transl)].
    Schöpf E
    Ther Umsch; 1976 Aug; 33(8):538-42. PubMed ID: 1006610
    [No Abstract]   [Full Text] [Related]  

  • 27. [Combined treatment of patients with metastases of skin melanoma using cryotherapy].
    Iavorskiĭ VV; Karaseva VV; Tokareva ZI
    Vopr Onkol; 1988; 34(7):799-803. PubMed ID: 3420821
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Introduction: Immunotherapy of cancer in man, a reality.
    Klein E
    Natl Cancer Inst Monogr; 1973 Dec; 39():139-61. PubMed ID: 4206961
    [No Abstract]   [Full Text] [Related]  

  • 29. [Experience with adjuvant chemoimmunotherapy with DTIC and BCG in malignant melanoma (author's transl)].
    Pullmann H; Muth M
    Z Hautkr; 1982 Feb; 57(4):294-7. PubMed ID: 7080583
    [No Abstract]   [Full Text] [Related]  

  • 30. Immunotherapy of melanoma: the good news, the bad ones and what to do next.
    Marincola FM; Ferrone S
    Semin Cancer Biol; 2003 Dec; 13(6):387-9. PubMed ID: 15001156
    [No Abstract]   [Full Text] [Related]  

  • 31. [Medical therapy of malignant melanoma].
    Mini E; Periti P
    Ann Ital Chir; 1989; 60(4):257-63. PubMed ID: 2699710
    [No Abstract]   [Full Text] [Related]  

  • 32. Adjuvant treatment of cancer. III. Malignant melanoma.
    Lundy J
    Conn Med; 1978 Apr; 42(4):220-2. PubMed ID: 639504
    [No Abstract]   [Full Text] [Related]  

  • 33. [Immuno- and chemoimmunotherapy and prevention of metastasis in skin melanoma].
    Trapeznikov NN; Iavorskiĭ VV; Vagner RI; Gorodilova VV; Knysh IT
    Vestn Akad Med Nauk SSSR; 1978; (5):19-26. PubMed ID: 676458
    [No Abstract]   [Full Text] [Related]  

  • 34. [Immunotherapy of cancer].
    Mäkelä O; Kaartinen M
    Duodecim; 1973; 89(18):1257-62. PubMed ID: 4771796
    [No Abstract]   [Full Text] [Related]  

  • 35. Treatment of malignant melanoma by intratumoral injection of BCG.
    Pinsky CM; Hirshaut Y; Oettgen HF
    Natl Cancer Inst Monogr; 1973 Dec; 39():225-8. PubMed ID: 4595322
    [No Abstract]   [Full Text] [Related]  

  • 36. Axillary lymphadenopathy: a complication of BCG immunotherapy for melanoma.
    Briggs PC; Heckler FR
    Plast Reconstr Surg; 1988 Jun; 81(6):952-3. PubMed ID: 3375359
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunotherapy of melanoma with BCG: two fatalities following intralesional injection.
    McKhann CF; Hendrickson CG; Spitler LE; Gunnarsson A; Banerjee D; Nelson WR
    Cancer; 1975 Feb; 35(2):514-20. PubMed ID: 234291
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunologic defects in melanoma patients: lack of effect of BCG therapy.
    Gersten MJ; Hadden EM; Kaplan MH; Pinsky CM; Armstrong D; Hadden JW
    Clin Bull; 1977; 7(2):63-9. PubMed ID: 902403
    [No Abstract]   [Full Text] [Related]  

  • 39. Adjuvant immunotherapy with BCG in stage II malignant melanoma.
    Byrne MJ; Van Hazel G; Reynolds PM; Lemish WM; Holman CD
    J Surg Oncol; 1983 Jun; 23(2):114-6. PubMed ID: 6343725
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Problems of immunotherapy in malignant melanoblastoma].
    Richter J; Duchková H
    Rozhl Chir; 1975 Jun; 54(6):411-8. PubMed ID: 1145346
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.